MedPath

Chlorhexidine

Generic Name
Chlorhexidine
Brand Names
Betasept, Hibiclens, Instillagel, Nupro Chlorhexidine, Oris, Oro-Clense, Paroex, Perichlor, Peridex, Periochip, Periogard, Prevora, X-pur
Drug Type
Small Molecule
Chemical Formula
C22H30Cl2N10
CAS Number
55-56-1
Unique Ingredient Identifier
R4KO0DY52L
Background

Chlorhexidine is a broad-spectrum antimicrobial biguanide used as a topical antiseptic and in dental practice for the treatment of inflammatory dental conditions caused by microorganisms. It is one of the most common skin and mucous membrane antiseptic agents in use today. The molecule itself is a cationic bis-guanide consisting of two 4-chlorophenyl rings and two biguanide groups joined by a central hexamethylene chain. Topical chlorhexidine for disinfection, as well as oral rinses for dental use, carries activity against a broad range of pathogens including bacteria, yeasts, and viruses.

Chlorhexidine was developed in the UK by Imperial Chemical Industries in the early 1950s and was introduced to the US in the 1970s. The FDA withdrew its approval for the use of chlorhexidine gluconate topical tincture 0.5%, due to a significant number of reports concerning chemical and thermal burns associated with the use of this product. Other formulations of chlorhexidine continue to be available.

Indication

Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.

Associated Conditions
Aphthous ulcer, Catarrh of the throat, Chemotherapy Induced Oral Mucositis, Chronic Wounds, Decubitus Ulcer, Dental Cavity, Dysphagia, Eczema infected, Foeter Ex Ore, Gingival Bleeding, Gingival Diseases, Gingivitis, Glossitis, Hoarseness, Infection, Infectious Periodontal Diseases, Injury Throat, Mild to Moderate Inflammatory Reaction of the Oral Cavity, Mild to Moderate Inflammatory Reaction of the Pharynx, Mouth injury, Mucositis, Neurodermatitis, Ocular Inflammation, Ocular Irritation, Oral Aphthous Ulcer, Pain, Periodontitis, Pharyngitis, Plaque, Dental, Postoperative Wound Infection, Purulent Gingivitis, Radiation Mucositis, Red eye, Ringworm, Skin Infections, Sore Throat, Stomatitis, Surgical Wounds, Tissue Damage, Tonsillitis, Ulcers, Leg, Wound Infections, Bacterial skin infections, Dry, cracked skin, Gum pain, Moderate Gingivitis, Oral infections, Oral lesions, Recurrent Oral fungal infection, Severe Gingivitis, Superficial Wounds, Throat disinfection, Tongue inflammation
Associated Therapies
Anesthesia of Mucous Membrane, Antimicrobial Therapy, Contact Lens Care, Disinfection, Disinfection of External Genitalia, Disinfection of the Urethra, Disinfection of the Vaginal Mucosa, Irrigation therapy, Lubrication of the Urethra, Oral Care, Oral Hygiene, Oropharyngeal antisepsis, Promotion of wound healing, Skin disinfection, Surgical Scrubbing, Topical Antisepsis, Urethral Anesthesia, Wound Cleansing, Oral antisepsis, Oral disinfection

Vaginal Cleansing With Chlorhexidine Versus Iodine for Prevention of Endometritis

Not Applicable
Completed
Conditions
Endometritis
Vaginal Cleansing
Post Caesarean
Interventions
First Posted Date
2025-04-20
Last Posted Date
2025-05-01
Lead Sponsor
Federal Teaching Hospital Abakaliki
Target Recruit Count
239
Registration Number
NCT06936475
Locations
🇳🇬

Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi, Nigeria

Chlorhexidine Versus N-Asetil Sistein Irrigation in Mandibular Molar Teeth with Chronic Apical Periodontitis

Not Applicable
Completed
Conditions
Chronic Apical Periodontitis
Interventions
First Posted Date
2025-02-19
Last Posted Date
2025-02-20
Lead Sponsor
Cukurova University
Target Recruit Count
78
Registration Number
NCT06834711
Locations
🇹🇷

Cukurova University, Adana, Sarıçam, Turkey

Comparison of Effectiveness of Disinfectants

Phase 1
Completed
Conditions
Root Canal Infection
Interventions
First Posted Date
2025-02-06
Last Posted Date
2025-02-06
Lead Sponsor
Armed Forces Institute of Dentistry, Pakistan
Target Recruit Count
124
Registration Number
NCT06811779
Locations
🇵🇰

Armed Forces Institute of Dentistry, Rawalpindi, Punjab, Pakistan

Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing In Stage I /II and Grade B Periodontitis - Randomized Control Clinical Trail

Phase 1
Completed
Conditions
Periodontal Pocket
Interventions
Procedure: SRP
Drug: bromelain-quercetin gel
First Posted Date
2025-01-15
Last Posted Date
2025-01-15
Lead Sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Target Recruit Count
30
Registration Number
NCT06775392
Locations
🇮🇳

Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI, Bengaluru, Karnataka, India

Evaluation of the Effect of a Toothpaste Containing 0.3% Chlorhexidine in Subjects With Established Dental Plaque and Gingivitis

Phase 3
Recruiting
Conditions
Gingivitis
Gingivitis and Periodontal Diseases
Gingival Disease
Dental Plaque
Interventions
First Posted Date
2024-12-13
Last Posted Date
2025-04-14
Lead Sponsor
Colgate Palmolive
Target Recruit Count
80
Registration Number
NCT06732466
Locations
🇧🇷

Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil

The Effect of Two Different Oral Care Solutions on the Prevention of Ventilator-associated Pneumonia in the Intensive Care Unit

Not Applicable
Active, not recruiting
Conditions
Intensive Care Patients
Oral Care Performance
Intensive Care Nurses
Interventions
First Posted Date
2024-12-13
Last Posted Date
2024-12-13
Lead Sponsor
MELEK UNLUGEDIK
Target Recruit Count
50
Registration Number
NCT06733090
Locations
🇹🇷

Istanbul University Cerrahpasa, Istanbul, Avcilar, Turkey

A Pilot Study to Evaluate Skin Swabbing with Chlorhexidine to Prevent Skin and Soft Tissue Infections Among People Who Inject Drugs

Phase 4
Completed
Conditions
Opioid Use Disorder
Infection Control and Prevention
Injection Drug Use
Interventions
Drug: Isopropyl Alcohol 70% Topical Application Solution
Behavioral: Skin Prep Before Injecting Recreational/Street Drugs
First Posted Date
2024-12-13
Last Posted Date
2024-12-13
Lead Sponsor
Gabriel John Culbert
Target Recruit Count
56
Registration Number
NCT06733506
Locations
🇺🇸

University of Illinois Chicago, Chicago, Illinois, United States

Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO)

Phase 2
Not yet recruiting
Conditions
Sarcoma,Soft Tissue
Interventions
Drug: 2% intranasal mupirocin ointment
First Posted Date
2024-12-02
Last Posted Date
2025-04-24
Lead Sponsor
Adam Olson
Target Recruit Count
31
Registration Number
NCT06712433
Locations
🇺🇸

UPMC Hillman Cancer Centers, Pittsburgh, Pennsylvania, United States

Effect of Chlorhexidine Gluconate in Oral Care of Patients With Endotracheal Intubation Based on 16sRNA Technology

Not Applicable
Completed
Conditions
Intubation, Endotracheal
Oral Hygiene
Interventions
Other: normal saline
First Posted Date
2024-11-15
Last Posted Date
2024-11-15
Lead Sponsor
Shanghai 10th People's Hospital
Target Recruit Count
76
Registration Number
NCT06691841
Locations
🇨🇳

Changcui Qiu, Shanghai, China

Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG

Phase 2
Completed
Conditions
Cutaneous Ulcer Disease
Skin Sores
Interventions
Other: Ficus septica exudate (antiseptic plant exudates)
Other: Pterocarpus indicus exudate
Other: Curcuma longa aqueous extract
First Posted Date
2024-11-15
Last Posted Date
2024-11-28
Lead Sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Target Recruit Count
370
Registration Number
NCT06690814
Locations
🇵🇬

Vunapope Hospital, Kokopo, EAST NEW Britan, Papua New Guinea

© Copyright 2025. All Rights Reserved by MedPath